Releases

Nano Announces Lead Investor Commitment for $90 Million Funding Round

AUSTIN, Texas and DUBAI, UAE (Arab Newswire)  --  Nano Cures Inc. (“Nano”), a clinical stage biotechnology and infectious disease immunity platform company, today announced a $90M pre-IPO funding round. The investment will be led by a $20M commitment from Opulence Capital Management, a Dubai based private investment fund, with existing and new investors participating. The investment will...